Angiogenesis inhibitors for metastatic colorectal cancer

被引：3
作者：
Pfeiffer, Per [1 ,2 ,4 ]
Liposits, Gabor [2 ,3 ]
Taarpgaard, Line Schmidt [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Oncol, Odense, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[3] Godstrup Hosp, Dept Oncol, Herning, Denmark
[4] Odense Univ Hosp, Dept Oncol, Sdr Blvd 29, DK-5000 Odense, Denmark
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 12期
关键词：
Colorectal cancer (CRC); angiogenesis inhibitors; fruquintinib; BEVACIZUMAB; PLACEBO; FRUQUINTINIB; MULTICENTER; EFFICACY; TAS-102;
D O I：
10.21037/tcr-23-1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3241 / 3244
页数：4
相关论文
共 16 条
  • [1] Chemotherapy Usage Patterns in a US-Wide Cohort of Patients With Metastatic Colorectal Cancer
    Abrams, Thomas A.
    Meyer, Gary
    Schrag, Deborah
    Meyerhardt, Jeffrey A.
    Moloney, Julie
    Fuchs, Charles S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (02):
  • [2] Subtyping or not subtyping-Quo vadis for precision medicine of colorectal cancer
    Avagyan, Susanna
    Binder, Hans
    [J]. TRANSLATIONAL CANCER RESEARCH, 2023, 12 (05) : 1067 - 1072
  • [3] Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
    Ayer Botrel, Tobias Engel
    de Oliveira Clark, Luciana Gontijo
    Paladini, Luciano
    Clark, Otavio Augusto C.
    [J]. BMC CANCER, 2016, 16
  • [4] Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis
    Baraniskin, Alexander
    Buchberger, Barbara
    Pox, Christian
    Graeven, Ulli
    Holch, Julian W.
    Schmiegel, Wolff
    Heinemann, Volker
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 106 : 37 - 44
  • [5] Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Cervantes, A.
    Adam, R.
    Rosello, S.
    Arnold, D.
    Normanno, N.
    Taieb, J.
    Seligmann, J.
    De Baere, T.
    Osterlund, P.
    Yoshino, T.
    Martinelli, E.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 (01) : 10 - 32
  • [6] Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
    Dasari, Arvind
    Lonardi, Sara
    Garcia-Carbonero, Rocio
    Elez, Elena
    Yoshino, Takayuki
    Sobrero, Alberto
    Yao, James
    Garcia-Alfonso, Pilar
    Kocsis, Judit
    Gracian, Antonio Cubillo
    Sartore-Bianchi, Andrea
    Satoh, Taroh
    Randrian, Violaine
    Tomasek, Jiri
    Chong, Geoff
    Paulson, Andrew Scott
    Masuishi, Toshiki
    Jones, Jeremy
    Csoszi, Tibor
    Cremolini, Chiara
    Ghiringhelli, Francois
    Shergill, Ardaman
    Hochster, Howard S.
    Krauss, John
    Bassam, Ali
    Ducreux, Michel
    Elme, Anneli
    Faugeras, Laurence
    Kasper, Stefan
    Van Cutsem, Eric
    Arnold, Dirk
    Nanda, Shivani
    Yang, Zhao
    Schelman, William R.
    Kania, Marek
    Tabernero, Josep
    Eng, Cathy
    [J]. LANCET, 2023, 402 (10395) : 41 - 53
  • [7] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [8] Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
    Grothey, Axel
    Van Cutsem, Eric
    Sobrero, Alberto
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Tabernero, Josep
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Cupit, Lisa
    Wagner, Andrea
    Laurent, Dirk
    [J]. LANCET, 2013, 381 (9863) : 303 - 312
  • [9] Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
    Hansen, Torben Frostrup
    Qvortrup, Camilla
    Pfeiffer, Per
    [J]. CANCERS, 2021, 13 (05) : 1 - 19
  • [10] Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
    Li, Jin
    Qin, Shukui
    Xu, Rui-Hua
    Shen, Lin
    Xu, Jianming
    Bai, Yuxian
    Yang, Lei
    Deng, Yanhong
    Chen, Zhen-dong
    Zhong, Haijun
    Pan, Hongming
    Guo, Weijian
    Shu, Yongqian
    Yuan, Ying
    Zhou, Jianfeng
    Xu, Nong
    Liu, Tianshu
    Ma, Dong
    Wu, Changping
    Cheng, Ying
    Chen, Donghui
    Li, Wei
    Sun, Sanyuan
    Yu, Zhuang
    Cao, Peiguo
    Chen, Haihui
    Wang, Jiejun
    Wang, Shubin
    Wang, Hongbing
    Fan, Songhua
    Hua, Ye
    Su, Weiguo
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (24): : 2486 - 2496
12